to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
In the healthcare business landscape, there's plenty of healthcare investing happening. However, there are still medical problems that could benefit from more investment. Read more about them.
In Part Two of our look at early-stage entrepreneurial funding, we examine the pros and cons of the two primary startup funding mechanisms: venture capital and angel funding.
As year-end approaches and entrepreneurs regroup to figure out financing options for 2012, it's a good time to take a look at the two major sources of new business funding -- angel investing versus venture capital.
As a partner at Kleiner Perkins Caufield & Byers, Dana Mead supports entrepreneurs and innovators seeking to make major impact through life science technologies and ventures. In this lecture, Mead talks about Venture Capital, offering great insights about Silicon Valley and life as a venture capitalist.
The number of life sciences venture deals was down in the third quarter and first-time funding was down as well. Read more about the reasons behind the numbers.
Venture firms are approaching angel investor groups to co-invest at the growth stage of startups. Read more about the impact this could have on startup health IT companies.
Medical foundations play a role in helping medicine advance through their philanthropy, but sometimes even the most well-intentioned of them can lose their way. Read more about how these foundations can stay focused on their goals.
Can "boom and bust" cycles exist in the venture funding market? You bet they can. And recent data from the chemical sector is a great example of how and why.
In a venture funding climate seeking large returns, thousands of potentially successful entrepreneurial startups can't get the financing they need to make a difference in the economy and in the culture. The problem isn't a new one, but it is a damaging one.
The number of healthcare venture deals is at its lowest level in at least five quarters, according to a new report. However, healthcare seed investment hit a record high in the same quarter.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.